InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Leen Ann M., Directeur Scientifique. Director active across 1 company, notably Allovir, Inc.. Aggregated, 6 filings have been logged. Split: 0 buy · 4 sells. Total volume traded: €6.2m. History available since 10 May 2021. The latest transaction was filed on 18 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
23,256 shares0Common StockSEC:0001209191-23-006990:0
15,000 shares0Common StockSEC:0000899243-22-029062:0
14,266 shares@ US$22.26474.5% of flowCommon StockSEC:0000899243-21-044889:0
14,266 shares@ US$22.26479.0% of flowCommon StockSEC:0000899243-21-044889
150,000 shares@ US$22.7545.5% of flowCommon StockSEC:0001209191-21-031337
150,000 shares@ US$22.7545.5% of flowCommon StockSEC:0001209191-21-031337:0
6 of 6 declarations
About Leen Ann M.
Ann M. Leen is the Chief Scientific Officer at Allovir, Inc. She is responsible for leading the company's research and development initiatives. Leen brings extensive scientific expertise and plays a crucial role in innovation and the development of new treatments. Her leadership contributes to advancing the company's scientific goals.
